- Bello-Madruga, Roberto
- Sandín, Daniel
- Valle, Javier
- Gómez, Jordi
- Comas, Laura
- Larrosa, María Nieves
- González-López, Juan José
- Jiménez, M. Angeles
- Andreu, David
- Torrent, Marc
Glycosaminoglycan (GAG)-binding proteins regulating essential processes such as cell growth and migration are essential for cell homeostasis. As both GAGs and the lipid A disaccharide core of Gram-negative bacteria contain negatively charged disaccharide units, we hypothesized that GAG-binding proteins could also recognize LPS and enclose cryptic antibiotic motifs. Here, we report novel antimicrobial peptides (AMPs) derived from heparin-binding proteins (HBPs), with specific activity against Gram-negative bacteria and high LPS binding. We used computational tools to locate antimicrobial regions in 82% of HBPs, most of those colocalizing with putative heparin-binding sites. To validate these results, we synthesized five candidates [HBP-1-5] that showed remarkable activity against Gram-negative bacteria, as well as a strong correlation between heparin and LPS binding. Structural characterization of these AMPs shows that heparin or LPS recognition promotes a conformational arrangement that favors binding. Among all analogs, HBP-5 displayed the highest affinity for both heparin and LPS, with antimicrobial activities against Gram-negative bacteria at the nanomolar range. These results suggest that GAG-binding proteins are involved in LPS recognition, which allows them to act also as antimicrobial proteins. Some of the peptides reported here, particularly HBP-5, constitute a new class of AMPs with specific activity against Gram-negative bacteria., Financial support from the Spanish Ministry of Economy and Innovation (PDC2021-121544-I00 funded by MCIN/AEI/10.13039/501100011033 and European Union Next Generation EU/ PRTR to MT; project PID2020-114627RB-I00 funded by MCIN/AEI/10.13039/501100011033 to MT; PID2020-112821GB-I00 funded by MCIN/AEI/10.13039/501100011033 to MAJ and PID2020-113184RB-C22 to DA), the Departament de Recerca iUniversitats de la Generalitat de Catalunya (2023PROD00021 to MT), and from La Caixa Banking Foundation (HR17-00409, to DA). This work has been co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union Next Generation EU, from the Recovery, Transformationand Resilience Plan (PRTR-C17.I1), European Society of Clinical Microbiologyand Infectious Diseases (ESCMID) ESCMID2022 and from the Autonomous Community of Catalonia within the framework of the Biotechnology PlanApplied to Health. Work at UPF was funded by the MCI María de Maeztu network of Units of Excellence. NMR experiments were performed in the“Manuel Rico” NMR laboratory (LMR) of the Spanish National ResearchCouncil (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). DS and RBM are recipients of pre-doctoral a FPI scholarship (PRE2018-083243 and PRE2021-097678, respectively) from the Spanish Ministry ofScience and Innovation, Peer reviewed